Zoledronic acid reduces the recurrence of breast cancer in post-menopausal women
Sunday, September 25, 2011 - 12:30
in Health & Medicine
A trial investigating the use of zoledronic acid to aid chemotherapy for breast cancer has found a significant benefit for post-menopausal women, according to results presented at the 2011 European Multidisciplinary Cancer Congress today. Researchers think it could be the key for a greater understanding of the mechanisms of breast cancer recurrence as well as offering new options for patient care.
